Associate Director, Analytical Development and QC - Foghorn Therapeutics

Our Culture: Why work with us?

At Foghorn Therapeutics, we believe in “People First, Mission Always.”

We put “People First” because we know our people are the key to everything we will accomplish. We value the diversity of background, ideas, perspectives and experiences that our team members bring to Foghorn Therapeutics – demonstrated by our community speaking more than 22 languages and representing over 24 nationalities. We value our teammates as people, not just as employees – validated by our actions that let our people know that we care about them, their families, and their lives.

We say “Mission Always” because we know a relentless commitment to our mission will make a difference in the lives of others. We believe our success will come from evaluating the data to follow the science. We work hard to develop a new class of therapies that could improve the lives of over 2.5 million people with cancer.

Our culture is focused on succeeding through the evaluation of data, not people. And in that, relationships can flourish and develop.

Our Science:

The groundbreaking science behind our therapies continues to yield vital insights into diseases that have confounded physicians and researchers. Our core scientific approach is centered on the chromatin regulatory system, which opens and closes the right sections of DNA at the right time. Breakdowns in the chromatin regulatory system lead to a wide range of diseases, including cancer, impacting millions of people.

Our proprietary Gene Traffic Control® platform is a powerful tool for understanding and modulating the chromatin regulatory system. We are pursuing multiple treatments for breakdowns in this system. We are the only company with the ability to study and target the chromatin regulatory system at scale, in context, and in an integrated way.

Job Summary

The Principal Scientist of Analytical Development and QC at Foghorn Therapeutics will drive the analytical development and QC functions, ensuring the successful advancement of small molecule candidates from preclinical through NDA for both drug substances and drug products. The successful candidate needs to demonstrate hands-on novel analytical development skills and a proven track record of managing CROs and CDMOs. Experience with long acting injectable product development is a plus. This position will report to the Vice President of CMC, Supply Chain, Quality Assurance.

This role is on-site.

Responsibilities

• Develop novel analytical method for long-acting injectable product hands-on at internal CMC lab
• Lead and oversee CRO/CDMO partnerships in the development and validation of analytical methods, utilizing phase-appropriate approaches for assays, purity, dissolution methodologies, impurity identification, degradation products, reference standard qualification, and physical characterization.
• Develop and implement a phase-appropriate quality control strategy for both drug substances and drug products.
• Manage product stability study programs to ensure compliance and efficacy.
• Author analytical development and validation reports, as well as analytical sections for IND and NDA filings.
• Collaborate with QA, Regulatory, and other CMC functions, clinical, and toxicology teams to address safety-related questions on APIs, components of APIs, formulations, and materials used in processing.
• Serve as the CMC representative on cross-functional project teams to ensure alignment and integration of analytical development with broader project goals.

Requirements

Qualifications

• PhD in Analytical Chemistry or related field with 10+ years of analytical development experience in the pharmaceutical industry.
• A desire to develop novel analytical method at internal CMC lab for long acting injectable product
• Proven track record of developing analytical methods and managing CROs and CDMOs on analytical projects.
• Extensive experience in drafting analytical sections of INDs and NDAs.
• Demonstrated ability to draft, review, and submit documentation in compliance with cGMP and GLP environments.
• Strong background in implementing phase-appropriate quality control strategies.
• Excellent scientific knowledge in analytical and organic chemistry.
• Proficient in analytical method development and validation.
• Comprehensive knowledge of quality control strategies for drug substances and drug products.
• Effective verbal and written communication skills.
• Proven ability to work successfully in cross-functional teams, representing the CMC function.

Benefits

Foghorn Therapeutics is pleased to provide you and your family with a comprehensive suite of benefits, including:

• Highly competitive and inclusive medical, dental and vision coverage options
• BCBS PPO and PPO HSA plans
• BCBS Dental Plan
• EyeMed Vision Plan
• FSA and HSA for medical expenses and dependent care expenses
• 401(k) Program via Fidelity with the company match
• Corporate Wellness Program
• Unlimited Paid Time Off policy
• Winter shut down
• 12 weeks of 100% paid parental leave for birthing/primary parent and primary guardian in case of adoption and 3 weeks of 100% paid parental leave for non-birthing/non-primary parent/guardian.
• Paid Life, LTD and STD insurance coverages, as well as voluntary benefit options
• Free parking, subsidized commuter passes, or a $100 monthly stipend for walking/biking to work
• Company lunches on Wednesdays
  

Foghorn Therapeutics is a smoke-free, alcohol-free and drug-free work environment.

Foghorn is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Foghorn Therapeutics will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.